FDG-PET in Hodgkin lymphoma

被引：0
|
作者：
Kobe, C. [1 ]
Dietlein, M. [1 ]
Mauz-Koerholz, C. [4 ]
Engert, A. [2 ,3 ]
Borchmann, P. [2 ,3 ]
Sabri, O. [5 ]
Schober, O. [6 ]
Schicha, H. [1 ]
Kluge, R. [5 ]
机构：
[1] Univ Cologne, Nukl Med Klin & Poliklin, D-50937 Cologne, Germany
[2] Univ Cologne, Innere Med Klin 1, D-50937 Cologne, Germany
[3] Univ Cologne, Deutsch Hodgkin Studien Grp GHSG, D-50937 Cologne, Germany
[4] Univ Halle Wittenberg, Univ Klin & Poliklin Kinder & Jugendmed, Halle, Germany
[5] Univ Leipzig, Nukl Med Klin & Poliklin, Leipzig, Germany
[6] Univ Klinikum Munster, Nukl Med Klin & Poliklin, Munster, Germany
来源：
NUKLEARMEDIZIN-NUCLEAR MEDICINE | 2008年 / 47卷 / 06期
关键词：
PET; Hodgkin lymphoma; response-adapted design; chemotherapy; radiotherapy;
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
The high negative predictive value of FDG-PET in therapy control of Hodgkin lymphoma is proven by the data acquired up to now. Thus, the analysis of the HD15 trial has shown that consolidation radiotherapy might be omitted in PET negative patients after effective chemotherapy. Further response adopted therapy guided by PET seems to be a promising approach in reducing the toxicity for patients undergoing chemotherapy. The criteria used for the PET inteipfetation have been standardized by the German study groups for Hodgkin lymphoma patients and will be reevaluated in the current studies.
引用
收藏
页码：235 / 238
页数：4
相关论文
共 50 条
  • [1] FDG-PET in Hodgkin Lymphoma
    Hutchings, M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S16 - S16
  • [2] FDG-PET in Hodgkin's lymphoma
    Ruth Kirby
    [J]. Nature Clinical Practice Oncology, 2005, 2 (10): : 485 - 486
  • [3] FDG-PET in the clinical management of Hodgkin lymphoma
    Hutchings, M
    Eigtved, AI
    Specht, L
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2004, 52 (01) : 19 - 32
  • [4] FDG-PET in the Staging of Patients with Hodgkin's Lymphoma
    Castagnoli, A.
    Versari, A.
    Rigacci, L.
    Gallamini, A.
    Matteini, M.
    Gregianin, M.
    Bianchi, A.
    Peano, S.
    Merli, F.
    Vaggelli, L.
    Levis, A.
    Chisesi, T.
    Pelosi, E.
    Biggi, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S145 - S145
  • [5] The role of FDG-PET in pediatric Non-Hodgkin lymphoma
    Nakatani, K.
    Nakamoto, Y.
    Suga, T.
    Miyake, K. K.
    Kurihara, K.
    Saga, T.
    Higashi, T.
    Togashi, K.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S434 - S434
  • [6] Role of FDG-PET in Staging and Therapy of Children with Hodgkin Lymphoma
    Kluge, R.
    Koerholz, D.
    [J]. KLINISCHE PADIATRIE, 2011, 223 (06): : 315 - 319
  • [7] Current Role of FDG-PET in Pediatric Hodgkin's Lymphoma
    Kluge, Regine
    Kurch, L.
    Georgi, Thomas
    Metzger, Monika
    [J]. SEMINARS IN NUCLEAR MEDICINE, 2017, 47 (03) : 242 - 257
  • [8] Our FDG-PET experience in paediatric Hodgkin and non-Hodgkin lymphoma
    Carena, M.
    Cossalter, E.
    Zecca, M.
    Locatelli, F.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S204 - S204
  • [9] Role of FDG-PET/CT in Management of Hodgkin's Lymphoma
    Gupta, Arun Kumar
    Kandasamy, Devasenathipathy
    Seth, Rachna
    [J]. INDIAN JOURNAL OF PEDIATRICS, 2009, 76 (12): : 1273 - 1274
  • [10] Role of FDG-PET/CT in management of Hodgkin’s lymphoma
    Arun Kumar Gupta
    Devasenathipathy Kandasamy
    Rachna Seth
    [J]. The Indian Journal of Pediatrics, 2009, 76 : 1273 - 1274
12345